Generic placeholder image

Current Radiopharmaceuticals

Editor-in-Chief

ISSN (Print): 1874-4710
ISSN (Online): 1874-4729

Research Article

Analytical GC-FID Method for the Determination of Organic Solvents in Radiopharmaceuticals

Author(s): Hishar Hassan, Muhammad Faiz Othman, Zainul Amiruddin Zakaria, Fathinul Fikri Ahmad Saad and Hairil Rashmizal Abdul Razak*

Volume 14, Issue 2, 2021

Published on: 27 October, 2020

Page: [131 - 144] Pages: 14

DOI: 10.2174/1874471013999201027215704

Price: $65

Abstract

Background: Organic solvents play an indispensable role in most of the radiopharmaceutical production stages. It is almost impossible to remove them entirely in the final formulation of the product.

Objective: In this presented work, an analytical method by gas chromatography coupled with flame ionization detection (GC-FID) has been developed to determine organic solvents in radiopharmaceutical samples. The effect of injection holding time, temperature variation in the injection port, and the column temperature on the analysis time and resolution (R ≥ 1.5) of ethanol and acetonitrile was studied extensively.

Methods: The experimental conditions were optimized with the aid of further statistical analysis; thence, the proposed method was validated following the International Council for Harmonisation (ICH) Q2 (R1) guideline.

Results: The proposed analytical method surpassed the acceptance criteria including the linearity > 0.990 (correlation coefficient of R2), precision < 2%, LOD, and LOQ, accuracy > 90% for all solvents. The separation between ethanol and acetonitrile was acceptable with a resolution R > 1.5. Further statistical analysis of Oneway ANOVA revealed that the increment in injection holding time and variation of temperature at the injection port did not significantly affect the analysis time. Nevertheless, the variation in injection port temperature substantially influenced the resolution of ethanol and acetonitrile peaks (p < 0.05).

Conclusion: The proposed analytical method has been successfully implemented to determine the organic solvent in the [18F]fluoro-ethyl-tyrosine ([18F]FET), [18F]fluoromisonidazole ([18F]FMISO), and [18F]fluorothymidine ([18F]FLT).

Keywords: Organic solvent, organic solvent analysis, quality control, gas chromatography, flame ionization detection, DB-200, radiopharmaceuticals.

Graphical Abstract
[1]
Vermeulen, K.; Vandamme, M.; Bormans, G.; Cleeren, F. Design and Challenges of Radiopharmaceuticals. Semin. Nucl. Med., 2019, 49(5), 339-356.
[http://dx.doi.org/10.1053/j.semnuclmed.2019.07.001] [PMID: 31470930]
[2]
Wadsak, W.; Mitterhauser, M. Basics and principles of radiopharmaceuticals for PET/CT. Eur. J. Radiol., 2010, 73(3), 461-469.
[http://dx.doi.org/10.1016/j.ejrad.2009.12.022] [PMID: 20181453]
[3]
Antuganov, D.; Antuganova, Y.; Zykova, T.; Krasikova, R. Use of capillary electrophoresis for the determination of impurities in preparations of fluorine-18 labelled PET radiopharmaceuticals. J. Pharm. Biomed. Anal., 2019, 173, 68-74.
[http://dx.doi.org/10.1016/j.jpba.2019.05.016] [PMID: 31121456]
[4]
Richter, S.; Wuest, F. 18 F-labeled peptides: The future is bright. Molecules, 2014, 19(12), 20536-20556.
[http://dx.doi.org/10.3390/molecules191220536] [PMID: 25493636]
[5]
SNMMI. About Targeted Radioisotope Therapies SNMMI, 2020.
[6]
Tankiewicz, M.; Namieśnik, J.; Sawicki, W. “Analytical procedures for quality control of pharmaceuticals in terms of residual solvents content: Challenges and recent developments,” TrAC -. Trends Analyt. Chem., 2016, 80, 328-344.
[http://dx.doi.org/10.1016/j.trac.2015.09.008]
[7]
Witschi, C.; Doelker, E. Residual solvents in pharmaceutical products: Acceptable limits, influences on physicochemical properties, analytical methods and documented values. Eur. J. Pharm. Biopharm., 1997.
[http://dx.doi.org/10.1016/S0939-6411(96)00037-9]
[8]
Otero, R.; Carrera, G.; Dulsat, J.F.; Fábregas, J.L.; Claramunt, J. Static headspace gas chromatographic method for quantitative determination of residual solvents in pharmaceutical drug substances according to european pharmacopoeia requirements. J. Chromatogr. A, 2004, 1057(1-2), 193-201.
[http://dx.doi.org/10.1016/j.chroma.2004.09.023] [PMID: 15584239]
[9]
Cheng, C.; Liu, S.; Mueller, B.J.; Yan, Z. A generic static headspace gas chromatography method for determination of residual solvents in drug substance. J. Chromatogr. A, 2010, 1217(41), 6413-6421.
[http://dx.doi.org/10.1016/j.chroma.2010.08.016] [PMID: 20801455]
[10]
Klok, R.P.; Windhorst, A.D. Residual solvent analysis by gas chromatography in radiopharmaceutical formulations containing up to 12% ethanol. Nucl. Med. Biol., 2006, 33(7), 935-938.
[http://dx.doi.org/10.1016/j.nucmedbio.2006.07.003] [PMID: 17045174]
[11]
International Council for Harmonisation Of Technical Requirements for Pharmaceuticals for Human Use. Ich Q3C(R7) Impurities Residual Solvents. ICH Harmon. Guidel., 2018, 4(October), 2002.
[12]
Mihon, M.; Tuta, C.S.; Ion, A.C.; Niculae, D.; Lavric, V. Fast method for the determination of residual solvents in radiopharmaceutical products. Rev. Chim., 2017, 68(4), 666-670.
[http://dx.doi.org/10.37358/RC.17.4.5526]
[13]
Pharmacopoeia, E. “Limiting Residual Solvent Levels in Active Substances , Excipients and Medicinal Products,” 2008, 1, 639-646.
[14]
Farajzadeh, M.A.; Dehghani, H.; Yadeghari, A.; Khoshmaram, L. Extraction and preconcentration of residual solvents in pharmaceuticals using dynamic headspace-liquid phase microextraction and their determination by gas chromatography-flame ionization detection. Biomed. Chromatogr., 2017, 31(2), e3788.
[http://dx.doi.org/10.1002/bmc.3788] [PMID: 27425260]
[15]
Meinert, C.; Meierhenrich, U.J. A new dimension in separation science: comprehensive two-dimensional gas chromatography. Angew. Chem. Int. Ed., 2012, 51(42), 10460-10470.
[http://dx.doi.org/10.1002/anie.201200842] [PMID: 22965886]
[16]
Channing, M.A.; Huang, B.X.; Eckelman, W.C. Analysis of residual solvents in 2-[(18)F]FDG by GC. Nucl. Med. Biol., 2001, 28(4), 469-471.
[http://dx.doi.org/10.1016/S0969-8051(00)00213-4] [PMID: 11395321]
[17]
Qin, L.; Hu, C.; Yin, L. Establishment of a Knowledge Base for Prescreening Residual Solvents in Pharmaceuticals. Chromatographia, 2004, 59(7), 475-480.
[http://dx.doi.org/10.1365/s10337-004-0211-2]
[18]
Klick, S.; Sköld, A. Validation of a generic analytical procedure for determination of residual solvents in drug substances. J. Pharm. Biomed. Anal., 2004, 36(2), 401-409.
[http://dx.doi.org/10.1016/j.jpba.2004.06.014] [PMID: 15496336]
[19]
Fliszar, K.; Wiggins, J.M.; Pignoli, C.M.; Martin, G.P.; Li, Z. Analysis of organic volatile impurities in pharmaceutical excipients by static headspace capillary gas chromatography. J. Chromatogr. A, 2004, 1027(1-2), 83-91.
[http://dx.doi.org/10.1016/j.chroma.2003.08.086] [PMID: 14971487]
[20]
Raghani, A.R. High-speed gas chromatographic analysis of solvents in pharmaceuticals using solid phase microextraction. J. Pharm. Biomed. Anal., 2002, 29(3), 507-518.
[http://dx.doi.org/10.1016/S0731-7085(02)00085-7] [PMID: 12062651]
[21]
Hassan, H.; Bakar, S.A.; Halim, K.N.C.A.; Idris, J.; Nordin, A.J. Convenient and efficient method for quality control analysis of18F-fluorocholine: For a small scale GMP-based radiopharmaceuticals laboratory set-up. Curr. Radiopharm., 2016, 9(2)
[http://dx.doi.org/10.2174/1874471008666150527091956]
[22]
dos Santos Costa, C.L.; Ramos, D.P.; da Silva, J.B. “Multivariate optimization and validation of a procedure to direct determine acetonitrile and ethanol in radiopharmaceuticals by GC-FID,” Microchem. J., 2019, 147, 654-659.
[http://dx.doi.org/10.1016/j.microc.2019.03.050]
[23]
Bernardoni, F.; Halsey, H.M.; Hartman, R.; Nowak, T.; Regalado, E.L. Generic gas chromatography flame ionization detection method using hydrogen as the carrier gas for the analysis of solvents in pharmaceuticals. J. Pharm. Biomed. Anal., 2019, 165, 366-373.
[http://dx.doi.org/10.1016/j.jpba.2018.12.006] [PMID: 30580085]
[24]
International Council for Harmonisation Of Technical Requirements for Pharmaceuticals for Human Use. International Council for Harmonisation Of Technical Requirements for Pharmaceuticals for Human Use ICH Topic Q2 (R1) Validation of Analytical Procedures: Text and Methodology, 2006, 333, 7574-2006.
[25]
Shrivastava, A.; Gupta, V. Methods for the determination of limit of detection and limit of quantitation of the analytical methods. Chronicles Young Sci., 2011, 2(1), 21.
[http://dx.doi.org/10.4103/2229-5186.79345]
[26]
Nader, M.; Reindl, D.; Eichinger, R.; Beheshti, M.; Langsteger, W. Improved quality control of [18F]fluoromethylcholine. Nucl. Med. Biol., 2011, 38(8), 1143-1148.
[http://dx.doi.org/10.1016/j.nucmedbio.2011.05.006] [PMID: 21741257]
[27]
Operating Hints for Using Split/Splitless Injectors InjectorsRestek; Tech. Guid, 2002, p. 36.
[28]
Agilent Technologies. How to Set Injection Port Temperatures Appropriately for GC AnalysesHow to Set Injection Port Temperatures; , 2019, p. 1.
[29]
Taylor, T. GC temperature programming-10 things you absolutely need to know. LC GC N. Am., 2015, 33(6), 438.
[30]
Raymond, P.W. Introduction to analytical gas chromatography, 2018, 410, p. 26.
[31]
Master Organic Chemistry. “Ace Your Next Organic Chemistry,” Master Organic Chemistry, 2019 .www.masterorganicchemistry.com

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy